Scientific publications
1998
Thymidylate
synthase expression and activity : relation to S-phase parameters and
5-fluorouracil sensitivity
J.F. Mirjolet, M. Barberi-Heyob, J.L. Merlin, S. Marchal, M.C. Etienne, G. Milano and P. Bey
Br J Cancer, 1998 Jul,
78(1): 62-8
S9788
modulates P-gp and MRP mediated MDR in doxorubicin resistant
MCF7cells
F. Bichat, M.A. Solis Recendez, M.G. Poullain,
M.F. Poupon, D. Khayat and G. Bastian
Biochem Pharmacol., 1998 Aug 15, 56(4): 497-502
Multidrug
resistance genes (MRP) and (MDR1) expression in small cell lung
cancer xenografts : relationship with response to chemotherapy
Y. Canitrot, F. Bichat, S.P.C. Cole, R.G. Deeley, J.H. Gerlach, G. Bastian, F. Arvelo and M.F. Poupon
Cancer Lett., 1998 Aug 14,
130(1-2): 133-41
1997
Two
RNA-binding domains determine the RNA-binding specificity of
nucleolin
G. Serin,
G. Joseph, L. Ghisolfi, M. Bauzan, M. Erard, F. Amalric and P. Bouvet
Journal of Biological Chemistry, May 1997, 272(20): 13109-1
French
multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia
and solid tumours. Standardization of RT-PCR and preliminary
comparisons between RT-PCR and immunohistochemistry in solid tumours.
S. Chevillard, P. Vielh, P. Validire, J.P. Marie, A.M. Faussat, V.
Barbu, C. Bayle, J. Benard, C. Bonnal, J. Boutonnat, F. Calvo, J.
Charrier, A. Clary, P. Colosetti, L. Danel-Moore, P. Decremoux, C.
Delvincourt, F. Finat-Duclos, P. Genne, A. Kataki, J.C. Kouyoumdjan,
R. Lacave, C. Maugard, J.L. Merlin, M. Mousseau, F. Pinguet, V.
Quillien, M. Raphael, B. Richard, P. Verrelle and J. Robert
Leukemia, 1997 Jul, 11(7): 1095-106
Cytoskeleton
alterations in MCF7R, a multidrug resistant human breast cancer cell
line
F. Bichat, R. Mouawad, M.G. Solis Recendez, D. Khayat and G. Bastian
Anticancer Research, 1997 Sep-Oct, 17(5A): 3393-401
Dexamethasone
efflux associated with P-glycoprotein in human multidrug resistant
leukemic cell lines
J.F. Maillefert, O. Duchamp, C.
Piroth, E. Solary, C. Tavernier and P. Genne
Biologie Prospective. Comptes rendus du 9ème colloque de Pont-à-Mousson
Ed. M.M. Galteau, P. Delwaide, G. Siest and J. Henny, John
Libbey Eurotext, Paris, 1997, 489-92
Bivalent
hapten-bearing peptides designed for iodine-131 pretargeted
radioimmunotherapy
E. Janevick Ivanovska, E. Gautherot, M.
Hillairet de Boisferon, M. Cohen, G. Milhaud, A. Tartar, W. Rostene,
J. Barbet and A. Gruaz-Guyon
Bioconjug. Chem, 1997, 8(4): 526-533
Pretargeted
radioimmunotherapy using (131) I-labelled bivalent hapten-bearing
peptides
M. Hillairet de Boisferon, C. Manetti, O.
Raguin, E. Gautherot, W. Rostene, J. Barbet and A. Gruaz-Guyon
Letters
in Peptide Science, 1997, 4: 331-339
1995
Cinchonine
administrated per os: efficient to circumvent P-glycoprotein mediated
multidrug resistance in vivo
P. Genne, O. Duchamp, E.
Solary, J. Magnette, J.P. Belon and B. Chauffert
Anticancer Drug
Des, 1995 March, 10(2): 103-18
The
role of cell regulation and apoptosis triggering in determining the
sensitivity of leukemic cells to topoisomerase I and II inhibitors
L. Dubrez, F. Goldwasser, P. Genne, Y.
Pommier and E. Solary
Leukemia, 1995 Jun, 9(6): 1013-24
Circumvention
of confluence-dependent resistance in a human multidrug-resistant
colon cancer cell line
C. Garrido, B. Chauffert, D. Pinard, F.
Thibault, P. Genne, M. Assem and M.T. Dimanche-Boitrel
International Journal of Cancer, 1995 Jun 9, 61(6): 873-9
Cellular
Pharmacology of azatoxins (Topoisomerase-II and tubulin inhibitors)
in P-glycoprotein-positive and negative cell lines
B.
Eymin, E. Solary, S. Chevillard, L. Dubrez, F. Goldwasser, O.
Duchamp, P. Genne, F. Leteurtre and Y. Pommier
International of Cancer, 1995
Oct 9, 63(2): 268-75
Adding
a reverser (verapamil) to combined chemotherapy overrides resistance
in small-cell lung cancer xenografts
F. Arvelo, M.F.
Poupon, F. Bichat, F. Grossin, Y. Bourgeois, M. Jacrot, G. Bastian and
T. Le Chevalier
European Journal of Cancer, 1995 Oct,
31A(11): 1862-8
|
Home
Back
Top